Hint mode is switched on Switch off
Cbonds API
Integrate prices, fundamentals and corporate actions into your workflow

Get Global Stock Data via API

  • Prices & history
  • Fundamentals
  • Dividends & corporate actions

Trevi Therapeutics, ordinary share
TRVI, US89532M1018

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access
Add a stock to WL
Choose all Reset all
Save Close
Trevi Therapeutics, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Latest quotes

Try in 7-days Trial access

  • Get full online access to the database
  • Use our powerful bond screener
  • Track bond prices from 400+ sources
  • Smart Portfolio Monitoring
Unlock Data
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Trevi is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions.
  • Issuer
  • Full borrower / issuer name
    Trevi Therapeutics, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    TRVI
  • Placement
    07.05.2019
  • Lock up period
    180
  • Number of papers
    5,500,000
  • Volume of raised funds
    55 mln USD
  • Raised funds in USD
    -
  • Placement share
    30.95%
  • Final placement price
    10 USD
  • Price change since placement date
    -100%
  • By capitalization
    177.72 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    TRVI
  • Placement
    16.12.2024
  • Lock up period
    180
  • Number of papers
    12,500,000
  • Volume of raised funds
    50 mln USD
  • Raised funds in USD
    -
  • Placement share
    14.21%
  • Final placement price
    4 USD
  • Price change since placement date
    264.38%
  • By capitalization
    351.82 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    TRVI
  • Placement
    23.09.2022
  • Lock up period
    180
  • Number of papers
    58,322,517
  • Volume of raised funds
    27.51 mln USD
  • Raised funds in USD
    -
  • Placement share
    24.44%
  • Final placement price
    1.93 USD
  • Price change since placement date
    655.18%
  • By capitalization
    112.56 mln USD
Other placements of the issuer Hide

Indicators

IFRS/US GAAP reports

  • 2026

  • 2025

  • 2024

  • 2023

  • 2022

  • 2021

  • 2020

  • 2019

    • News

    All organization news

    Holders

    Related Stock indices

    • NASDAQ Composite
      26,939.37
      Value
      24/09/2026
      Date

    Industry Leaders

    Registration is required to get access.